In AF with recent ACS or PCI, apixaban improved 30-day outcomes vs. VKAs; aspirin effects varied vs. placebo
Sign Up to like & getrecommendations! Published in 2020 at "Annals of Internal Medicine"
DOI: 10.7326/acpj202009150-029
Abstract: SOURCE CITATION Alexander JH, Wojdyla D, Vora AN, et al. Risk/benefit tradeoff of antithrombotic therapy in patients with atrial fibrillation early and late after an acute coronary syndrome or percutaneous coronary intervention: insights from AUGUSTUS.… read more here.
Keywords: recent acs; pci apixaban; improved day; acs pci ... See more keywords